These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3335409)

  • 1. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous loss of bacteriophage receptor and coaggregation mediator activities in Actinomyces viscosus MG-1.
    Tylenda CA; Enriquez E; Kolenbrander PE; Delisle AL
    Infect Immun; 1985 Apr; 48(1):228-33. PubMed ID: 3980085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.
    Kolenbrander PE
    Infect Immun; 1982 Sep; 37(3):1200-8. PubMed ID: 7129635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Actinomyces bacteriophage from human dental plaque.
    Tylenda CA; Calvert C; Kolenbrander PE; Tylenda A
    Infect Immun; 1985 Jul; 49(1):1-6. PubMed ID: 4008044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.
    Cisar JO; Kolenbrander PE; McIntire FC
    Infect Immun; 1979 Jun; 24(3):742-52. PubMed ID: 468376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis.
    Kolenbrander PE; Williams BL
    Infect Immun; 1981 Jul; 33(1):95-102. PubMed ID: 7263074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
    Cisar JO; Vatter AE; McIntire FC
    Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polysaccharide from Streptococcus sanguis 34 that inhibits coaggregation of S. sanguis 34 with Actinomyces viscosus T14V.
    McIntire FC; Crosby LK; Vatter AE; Cisar JO; McNeil MR; Bush CA; Tjoa SS; Fennessey PV
    J Bacteriol; 1988 May; 170(5):2229-35. PubMed ID: 3360742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bacteriophage-resistant mutants to study Actinomyces viscosus cell surface receptors.
    Tylenda CA; Kolenbrander PE; Delisle AL
    J Dent Res; 1983 Nov; 62(11):1179-81. PubMed ID: 6580320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Streptococcus gordonii (S. sanguis) PK488 adhesin-mediated coaggregation with Actinomyces naeslundii PK606.
    Kolenbrander PE; Andersen RN
    Infect Immun; 1990 Sep; 58(9):3064-72. PubMed ID: 2387635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK; Paul A
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.
    McIntire FC; Crosby LK; Vatter AE
    Infect Immun; 1982 Apr; 36(1):371-8. PubMed ID: 7076303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interbacterial adherence between Actinomyces viscosus and strains of Streptococcus pyogenes, Streptococcus agalactiae, and Pseudomonas aeruginosa.
    Komiyama K; Gibbons RJ
    Infect Immun; 1984 Apr; 44(1):86-90. PubMed ID: 6423545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular coaggregation of oral Streptococcus milleri with actinomyces.
    Eifuku H; Yakushiji T; Mizuno J; Kudo N; Inoue M
    Infect Immun; 1990 Jan; 58(1):163-8. PubMed ID: 2294047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of Actinomyces spp. by genomic DNA of bacteriophages from human dental plaque.
    Yeung MK; Kozelsky CS
    Plasmid; 1997; 37(2):141-53. PubMed ID: 9169205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque.
    Palmer RJ; Gordon SM; Cisar JO; Kolenbrander PE
    J Bacteriol; 2003 Jun; 185(11):3400-9. PubMed ID: 12754239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Actinomyces and Streptococcus coaggregation groups among human oral isolates from the same site.
    Kolenbrander PE; Inouye Y; Holdeman LV
    Infect Immun; 1983 Aug; 41(2):501-6. PubMed ID: 6409807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.